Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 selinexor monotherapy in relapsed or refractory Richter's transformation
2014-001240-38Phase 2Completed
- Sponsor
- Karyopharm Therapeutics Inc.
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of selinexor in Richter's syndrome (RS) and diffuse large B-cell lymphoma (DLBCL), sponsored by Karyopharm Therapeutics Inc. Primary endpoints: Overall response rate and Duration of response. Started Jul 2014; status: completed.
02
Drugs
selinexor
03
Conditions
Richter's syndrome (RS)diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2014-001240-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001240-38.